Possible to use them for regenerative therapies, repairing damaged organs or tissues in the body, and treating conditions such as type I diabetes or liver disease
A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by scientists.
Using the technique, researchers have for the first time been able to grow a pure, self-renewing population of stem cells specific to the human foregut, the upper section of the human digestive system.
These so-called “Foregut stem cells” could then be developed further to produce liver or pancreatic cells. The method significantly improves on existing techniques for cultivating this type of stem cell, and raises the possibility that, with further work, they could be grown in large numbers in bioreactors. That would make it possible to use them for regenerative therapies, repairing damaged organs or tissues in the body, and treating conditions such as type I diabetes or liver disease.
“We have developed a cell culture system which allows us to specifically isolate foregut stem cells in the lab,” Dr Nicholas Hannan, from the University of Cambridge Wellcome Trust MRC Stem Cell Institute, Department of Surgery, explained. Hannan led the study, which was carried out in the lab of Dr Ludovic Vallier.
“These cells have huge implications for regenerative medicine, because they are the precursors to the thyroid upper airways, lungs, liver, pancreas, stomach and biliary systems. We now have a system where we may be able to create all these cell types from the same starting population.”
As reported in the journal Stem Cell Reports, the method also means that researchers will be able to analyse the embryonic development of foregut cells in greater depth. “We now have a platform from which we can study the early patterning events that occur during human development to produce the intestines, liver, lungs and pancreas,” Hannan added.
The approach marks a breakthrough because it overcomes some of the problems which currently limit scientists’ abilities to grow cells associated with the liver, pancreas, and other parts of the foregut in sufficiently large numbers for clinical use.
Stem cell growth starts with human pluripotent stem cells (hPSCs). These are non-specialised biological cells with the potential to transform – or “differentiate” – into any of the three primary layers of cells from which all tissues and organs develop. Because these cells also self-renew, creating copies of themselves, they offer the potential to provide an infinite source of clinically usable cells for regenerative medicine.
Go deeper with Bing News on:
Transplant therapies
- Children’s Minnesota Heart Transplant program receives CMS certificationon February 26, 2021 at 2:58 pm
After its start in 2018, the Heart Failure and Heart Transplant program at Children's Minnesota recently received certification.
- Combination Regimens for Multiple Myeloma Show Efficacy in the Transplant-Ineligible Population, According to Dinglion February 26, 2021 at 11:37 am
David Dingli, MD, PhD, professor of Medicine at the Mayo Clinic, reviews the combination therapies available for the treatment of multiple myeloma in a patient who is 72-years-old and ...
- Children's Minnesota receives heart transplant certificationon February 26, 2021 at 11:22 am
Children's Minnesota announced today that it received the Centers for Medicare and Medicaid Services (CMS) certification of its Heart Failure and Heart Transplant program. Children's Minnesota ...
- Virus can be transmitted via lung transplant; COVID-19 deadlier than flu for ICU patientson February 26, 2021 at 11:04 am
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. The coronavirus ...
- Total Body Irradiation Plus Etoposide Improves Survival in Select Transplant-Eligible Pediatric High-Risk ALLon February 25, 2021 at 2:33 pm
Total body irradiation plus etoposide prior to hematopoietic stem cell transplantation resulted in improved overall survival and a lower risk of relapse in pediatric patients with high-risk acute ...
Go deeper with Google Headlines on:
Transplant therapies
Go deeper with Bing News on:
Regenerative medicine
- Restore hair with regenerative medicine at The Osteopathic Centeron February 26, 2021 at 1:19 pm
We’re joined by Dr. Sean Goddard and Dr. Lowell McCauley from The Osteopathic Center to talk about the restoration process using regenerative medicine. Copyright 2021 Nexstar Inc. All rights reserved.
- Global Regenerative Medicine Market Share, Size, Trends, & Industry Analysis Report 2020-2026 by Therapy; Products; Application; Regionon February 25, 2021 at 6:08 am
The "Regenerative Medicine Market Share, Size, Trends, & Industry Analysis Report, By Therapy; By Products; By Application; By Region: Segment Forecast, 2020-2026" report has been added to ...
- Regenerative Medicine Market Size, Share, Industry Demand to Exhibit 9.3% CAGR till 2027 | Trend—High demand for stem cell technologyon February 24, 2021 at 12:28 pm
Regenerative Medicine Market is projected to reach USD 6.49 billion in 2027. The treatment of specific indications and chronic conditions is expected to have significant effects on healthcare.
- Global $79.23 Bn Regenerative Medicine Markets, Analysis 2015-2019 & Forecasts 2020-2026 - ResearchAndMarkets.comon February 24, 2021 at 4:36 am
The "Regenerative Medicine Market Share, Size, Trends, & Industry Analysis Report, By Therapy; By Products; By Application; By Region: Segment Forecast, 2020-2026" report has been added to ...
- New platform can help treat neurodegenerative diseases through regenerative medicineon February 23, 2021 at 9:03 pm
By discovering a new printable biomaterial that can mimic properties of brain tissue, Northwestern University researchers are now closer to developing a platform capable of treating these conditions ...